| 中文名 | PD 123319 二(三氟乙酸盐) |
|---|---|
| 英文名 | PD 123319 bistrifluoroacetate |
| 中文别名 |
(S)-1-(4-(二甲氨基)-3-甲基苄基)-5-(2,2-二苯基乙酰基)-4,5,6,7-四氢-1H-咪唑并[4,5-C]吡啶-6-甲酸 2,2,2-三氟乙酸 (1:2)
PD123319 DI(TRIFLUOROACETATE),ANGIOTENSIN AT2 RECTOR拮抗剂 |
| 英文别名 |
(S)-1-<<4-(dimethylamino)-3-methylphenyl>methyl>-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo<4,5-c>pyridine-6-carboxylic acid
(S)-1-(4-(Dimethylamino)-3-methylbenzyl)-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-cboxylic acid compound with 2,2,2-trifluoroacetic acid (1:2) 1H-Imidazo[4,5-c]pyridine-6-carboxylic acid, 1-[[4-(dimethylamino)-3-methylphenyl]methyl]-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-, (6S)-, compd. with 2,2,2-trifluoroacetic acid (1:2) (3S)-9-[(4-DIMETHYLAMINO-3-METHYL-PHENYL)METHYL]-4-(2,2-DIPHENYLACETYL)-4,7,9-TRIAZABICYCLO[4.3.0]NONA-7,10-DIENE-3-CARBOXYLIC ACID 1-((4-(Dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4.5-c]pyridine-6-carboxyli PD 123,319 hydrate di(trifluoroacetate) salt PD 123,319 DITRIFLUOROACETATE pd 123,319 di(trifluoroacetate) salt PD 123319 DITRIFLUOROACETATE, CID PD 123319 (ditrifluoroacetate) PD 123,319 di(trifluoroacetate) salt hydrate powder, >= (HPLC) (S)-1-[[4-(Dimethylamino)-3-methylphenyl]methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-cboxylic acid bis(trifluoroacetate) S-(+)-1-[(4-(Dimethylamino)-3-methylphenyl)methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-cboxylic acid hydrate di(trifluoroacetate) salt (6S)-1-[4-(Dimethylamino)-3-methylbenzyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid trifluoroacetate (1:2) S-(+)-1-[(4-(dimethylamino)-3-methylphenyl)methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid di(trifluoroacetate) PD123319 di(trifluoroacetate), angiotensin AT2 rector antagonist PD 123,319 di(trifluoroacetate) salt hydrate PD123319; PD-123319; S-+-PD S-(+)-1-((4-(dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazol(4,5-c)pyridine-6-carboxylic acid (S)-1-((4-(dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo(4,5-c)pyridine-6-carboxylic acid,difluoroacetate salt (6S)-1-[4-(Dimethylamino)-3-methylbenzyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid PD 123319 (trifluoroacetate salt) PD 123319 bis(trifluoroacetate) (S)-1-{[4-(dimethylamino)-3-methylphenyl]methyl}-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid PD 123,319 (S)-1-{[4-(dimethylamino)-3-methylphenyl]methyl}-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo-[4,5-c]pyridine-6-carboxylic acid,ditrifluoroacetate,dihydrate S-(+)-1-[(4-(Dimethylamino)-3-methylphenyl)methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-cboxylic acid di(trifluoroacetate) salt hydrate |
| 描述 | PD 123319 ditrifluoroacetate 是一种有效的,选择性的 AT2 angiotensin II receptor 拮抗剂,IC50 值为 34 nM。 |
|---|---|
| 相关类别 | |
| 靶点 |
IC50: 34 nM (AT2 Receptor)[1] |
| 体外研究 | PD 123319显示出在许多不同组织中区分AII受体的两个亚类。 125I-AII在牛肾上腺肾小球细胞的膜制剂中特异性标记AII的两类结合位点。第一类(DuP-753敏感)代表AII总结合位点的约85%,并且对DuP-753具有高亲和力(IC50为92.9nM)。 PD-123319对125I-AII与该位点的结合没有任何影响。第二类结合位点对PD-123319更敏感,IC50为6.9 nM,对DuP-753的亲和力低得多(IC50约为10 microM)[2]。 |
| 参考文献 |
| 分子式 | C35H34F6N4O7 |
|---|---|
| 分子量 | 736.657 |
| 精确质量 | 736.233154 |
| PSA | 115.97000 |
| LogP | 5.04700 |
| 储存条件 | 2-8℃ |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H315-H319-H335 |
| 警示性声明 | P261-P305 + P351 + P338 |
| 个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
| 危险品运输编码 | NONH for all modes of transport |